SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-21-000115
Filing Date
2021-12-16
Accepted
2021-12-16 09:17:26
Documents
21
Period of Report
2021-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20211214.htm   iXBRL 8-K 51247
2 EX-4.1 exhibit41formofwarrant.htm EX-4.1 114266
3 EX-4.2 exhibit42formofpre-fundedw.htm EX-4.2 109765
4 EX-5.1 exhibit51opinion.htm EX-5.1 19030
5 EX-10.1 exhibit101securitiespurcha.htm EX-10.1 243723
6 EX-99.1 exhibit991hcwengagementlet.htm EX-99.1 62197
7 EX-99.2 exhibit992pressrelease.htm EX-99.2 11791
11 image_0a.jpg GRAPHIC 1876
12 image_1a.jpg GRAPHIC 19853
13 image_1b.jpg GRAPHIC 8359
  Complete submission text file 0001698530-21-000115.txt   919317

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20211214.xsd EX-101.SCH 1905
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20211214_lab.xml EX-101.LAB 24831
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20211214_pre.xml EX-101.PRE 13045
14 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20211214_htm.xml XML 10984
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 211496148
SIC: 2834 Pharmaceutical Preparations